The results indicated a lower mRNA and protein expression of BCL-XL but an increased mRNA and protein expression of BAX in platelets treated with plasma from patients with ITP when compared to control plasma [91]. Here, BCL2L1 is linked to autoimmune thrombocytopenic purpura.